Givaudan SA Earnings Recaps
Q2 2026
Jul 26, 2026
Shares fell 5.5% following results that disappointed investors due to margin compression and cautious outlook amid weak performance in Taste & Wellbeing. The decline reflects concerns over declining adjusted EPS and continued challenges in key markets despite some sequential improvement.
Key takeaways
- Group sales rose 3.6% on a like-for-like basis but net income fell to CHF 475 million from CHF 592 million year-over-year.
- Adjusted EBITDA margin compressed to 24.3% from 25.2% in H1 2025, reflecting margin pressure despite solid volume growth.
- Taste & Wellbeing segment sales declined 6.3% in Swiss francs and showed only 0.5% like-for-like growth, highlighting ongoing market challenges.
- Fragrance & Beauty delivered mixed results with strong volume-led growth but weakness in Fragrance Ingredients and Active Beauty segments.
- Adjusted free cash flow was negative CHF 119 million in H1, impacted by higher investments and working capital timing, casting some doubt on cash generation near term.